Literature DB >> 10790877

Are A3 adenosine receptors expressed in the brain?

S A Rivkees1, S Thevananther, H Hao.   

Abstract

An increasing number of reports suggest a role for A3 adenosine receptors (A3ARs) in mediating adenosine action in the central nervous system. However, studies of A3AR localization in the brain have yet to be performed. To provide insights into the central sites of A3AR action, we compared patterns of A1 and A3AR mRNA and binding site expression in the brains of rats, mice and humans. We also assessed whether A3 agonists are selective for A3ARs. Whereas it was possible to detect high-level A1AR expression in many brain regions, it was not possible to detect either A3AR gene or binding site expression in the central nervous system. When we examined the affinities of the A3AR agonists CI-IAB-MECA and IAB-MECA for A1ARs, we found that these compounds bound to A1ARs with high affinity. These observations suggest that studies using A3-agonists need to consider potential effects of A1ARs activation, as A1ARs are abundantly expressed in the nervous system whereas A3AR expression in the brain cannot be directly demonstrated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790877     DOI: 10.1097/00001756-200004070-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  23 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Authors:  Chong-Bin Zhu; Kathryn M Lindler; Nicholas G Campbell; James S Sutcliffe; William A Hewlett; Randy D Blakely
Journal:  Mol Pharmacol       Date:  2011-06-24       Impact factor: 4.436

Review 3.  Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

4.  Role of nitric oxide in the behavioral and neurochemical effects of IB-MECA in zebrafish.

Authors:  Caio Maximino; Julliany Gemaque; Rancés Benzecry; Monica Gomes Lima; Evander de Jesus Oliveira Batista; Domingos Wanderley Picanço-Diniz; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Psychopharmacology (Berl)       Date:  2014-11-13       Impact factor: 4.530

Review 5.  Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

6.  A1 adenosine receptors inhibit multiple voltage-gated Ca2+ channel subtypes in acutely isolated rat basolateral amygdala neurons.

Authors:  B A McCool; J S Farroni
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 7.  Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia.

Authors:  Annalisa Pinna; Marcello Serra; Micaela Morelli; Nicola Simola
Journal:  J Neural Transm (Vienna)       Date:  2018-02-02       Impact factor: 3.575

8.  A1 adenosine receptors mediate hypoxia-induced ventriculomegaly.

Authors:  Christopher P Turner; Meltem Seli; Laura Ment; William Stewart; Henglin Yan; Bjorn Johansson; Bertil B Fredholm; Michael Blackburn; Scott A Rivkees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

9.  Species comparison of adenosine receptor subtypes in brain and testis.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Laura Fabbrini; Lara Schmid; Maura Castagna; Laura Giusti; Giovanni Mascia; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-07       Impact factor: 3.996

10.  Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.

Authors:  Irina M Fedorova; Marlene A Jacobson; Anthony Basile; Kenneth A Jacobson
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.